Inovio Pharmaceuticals's total assets for Q1 2025 were $87.27B, an increase of 76997.89% from the previous quarter. INO total liabilities were $36.02B for the fiscal quarter, a 80497.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.